Ibrance 75 MG capsule 21S
Ended Awarded
- Contract number
- SPE2DB26FQWXF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,124
Award facts
- Contract value 100% obligated
- $8,123.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count) on November 4, 2025, with an ultimate completion date of November 26, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
Ibrance is a targeted cancer therapy indicated for breast cancer treatment, and this procurement supports the Department of Defense's medical supply requirements for military healthcare systems and veteran services. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical portfolio spanning brand-name medications, generic drugs, vaccines, and specialized medical supplies. The parent SPE2DX contract functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply essential medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB26FQWXF?
SPE2DB26FQWXF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FQWXF worth?
The government has obligated $8,124 on SPE2DB26FQWXF.
Is contract SPE2DB26FQWXF an order under another contract?
Yes. SPE2DB26FQWXF is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB26FQWXF competed?
The extent of competition for SPE2DB26FQWXF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award